PULSE BIOSCIENCES INC reports a Return on Equity (ROE) of -112.47%.

What is PLSE's dividend yield?

PULSE BIOSCIENCES INC offers a dividend yield of 0.00%.

What is PLSE's Quality Score?

Our AI rates PLSE's overall financial quality at 23 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy PLSE?

Our AI Timing Score for PLSE is 91 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does PLSE belong to?

PULSE BIOSCIENCES INC is classified under the Healthcare >> Medical Instruments & Supplies sector on the NASDAQ exchange

PLSE (NASDAQ) Stock Analysis | PULSE BIOSCIENCES INC

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

PLSE AI Analysis Summary

Our AI summary for PLSE: PULSE BIOSCIENCES INC (NASDAQ), Healthcare >> Medical Instruments & Supplies sector. The stock currently trades at a P/E of 0.00, ROE of -112.47%, a dividend yield of 0.00%. Its financial Quality Score stands at 23/100 — fundamentals below the market average. The AI Timing Score is 91/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

PLSE

PULSE BIOSCIENCES INC

USD 35.13

0.09 (0.26%) Day Change

Watchlist Portfolio Compare Chart

0.02

D/E

-112.5%

ROE

-91.4%

ROA

0.00%

Div Yield

PULSE BIOSCIENCES INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 35.13 Price 0.09 (0.26%) Day Change	NEWS SCORE: 97

PLSE, the overall quality is not good ( Quality = 23) but the timing to buy is ...(Sign In to See)...

Loading chart...

23 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROE is relatively low.
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
Negative growth of ROE in the last year.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

In details, quality factors are not good , financial health is not good , and ability to make profit is not quite good , ...

Quality Factors

45%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	97
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	35.13
PBV / Sector	36.58 / 3.37
Earning Per Share	-1.08

PE / Sector	N/A / 44.25
PEG or PE/Growth / Sector	N/A / -1.35
Average 1M Daily Value	11.09 M GREAT
Average 1W Daily Value	17.88 M GREAT

Timing Factors

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

41%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Ability to Make Profit

56%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-9,929.03 / 82.17
NPM Average (%) / Sector	107,463.64 / 28.91 GOOD
NPM Change Average (%) / Sector	N/A / 208.28
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-91.36 / 7.70
ROA Average (%) / Sector	-70.92 / -22.17
ROA Change Average (%) / Sector	14.70 / 105.15 GOOD
ROE (%) / Sector	-112.47 / 10.10
ROE Average (%) / Sector	455.59 / 392.40 GREAT
ROE Change Average (%) / Sector	-9.13 / 109.80
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Return to Investors

Dividend (%) / Sector	N/A / 0.99
Dividend Average (%) / Sector	N/A / 1.43
Dividend Change Average (%) / Sector	N/A / 11.29

Registration Details

Analyze Date	2026-08-01 08:00:20
Symbol	PLSE
Name	PULSE BIOSCIENCES INC
Sector	Healthcare >> Medical Instruments & Supplies
Market	NASDAQ
Listed Shares	69.21 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	2,425.11 / 16,159.14

News, Concensus, ...

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 601 Brickell Key Drive, Miami, FL, United States, 33131

Phone: 510 906 4600

Website: https://www.pulsebiosciences.com

Employees: 116

Sector: Healthcare >> Medical Instruments & Supplies

Description: Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers nPulse System, a novel Nanosecond Pulsed-Field Ablation delivery platform to treat benign lesions of the skin; nPulse Vybrance Percutaneous Electrode system for soft tissue ablation in surgical setting; nPulse Cardiac Surgical Clamp designed for use in surgical treatment of atrial fibrillation (AF); nPulse Cardiac Catheter System designed to provide a circumferential, or circular, ablation in a single treatment cycle; and nPulse Console, a software-enabled console-based platform designed to accommodate the clinical workflow preferred by physicians. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Miami, Florida.